Cerebrospinal fluid in multiple sclerosis

<b>Background:</b> Technological advances have made it possible to examine the human cerebrospinal fluid (CSF) in a manner that was previously impossible. CSF provides a window into the changes that occur in the central nervous system (CNS) in health and disease. Through analysis of the...

Full description

Bibliographic Details
Published in:	Annals of Indian Academy of Neurology
Main Author:	Rammohan Kottil
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2009-01-01
Subjects:	Cerebrospinal fluid multiple sclerosis
Online Access:	http://www.annalsofian.org/article.asp?issn=0972-2327;year=2009;volume=12;issue=4;spage=246;epage=253;aulast=Rammohan

Similar Items

Cerebrospinal fluid biomarkers in multiple sclerosis
by: Hayrettin Tumani, et al.
Published: (2009-08-01)

Multiple sclerosis in Brazil: analysis of cerebrospinal fluid by standard methods
by: MARZIA PUCCIONI-SOHLER, et al.
Published: (1999-12-01)

Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study
by: Xingwei Fang, et al.
Published: (2023-06-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
by: Maria-Eleftheria Evangelopoulos, et al.
Published: (2022-11-01)

Quantitative Analysis of Cerebrospinal Fluid Brain Derived Neurotrophic Factor in the Patients with Multiple Sclerosis
by: Farhad Mashayekhi, et al.
Published: (2012-01-01)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
by: Ranjani Ganapathy Subramanian, et al.
Published: (2021-11-01)

Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid
by: Enedina Maria Lobato de OLIVEIRA, et al.
Published: (2019-10-01)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
by: Gregory F. Wu, et al.
Published: (2023-04-01)

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
by: Stephanie Herman, et al.
Published: (2019-01-01)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
by: Mario Stampanoni Bassi, et al.
Published: (2020-06-01)

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
by: Roberta Magliozzi, et al.
Published: (2021-07-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
by: I. V. Smagina, et al.
Published: (2010-08-01)

Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis
by: Margarete M. Voortman, et al.
Published: (2021-08-01)

Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis
by: Shinji Ashida, et al.
Published: (2022-09-01)

Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features
by: Xiang Zhang, et al.
Published: (2023-11-01)

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01)

Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal Fluid
by: Marco Puthenparampil, et al.
Published: (2022-05-01)

What does an isolated cerebrospinal fluid band mean: a tertiary centre experience
by: Turan Poyraz, et al.
Published: (2015-04-01)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
by: Júlia Costa, et al.
Published: (2021-07-01)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
by: Maria Marcella Laganà, et al.
Published: (2021-02-01)

Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
by: Chiara Lucchi, et al.
Published: (2024-08-01)

Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients
by: Massimiliano Castellazzi, et al.
Published: (2018-12-01)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
by: Franz Felix Konen, et al.
Published: (2022-07-01)

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
by: Frederike Straeten, et al.
Published: (2022-12-01)

Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids
by: Philip Meier, et al.
Published: (2024-10-01)

Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis
by: Haijie Liu, et al.
Published: (2022-04-01)

"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-08-01)

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
by: Deepali Mathur, et al.
Published: (2017-07-01)

Protein biomarkers in multiple sclerosis
by: Jun-Soon Kim
Published: (2023-04-01)

CXCL10 Is Associated with Increased Cerebrospinal Fluid Immune Cell Infiltration and Disease Duration in Multiple Sclerosis
by: Stephanie N. Blandford, et al.
Published: (2023-08-01)

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
by: Mariola Świderek-Matysiak, et al.
Published: (2023-02-01)

Oligoclonal band on the 5-year prognosis of patients with multiple sclerosis
by: Masoud Ghiasian, et al.
Published: (2025-03-01)

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes
by: Alexandra Rabin, et al.
Published: (2024-09-01)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
by: Andrea Burgetova, et al.
Published: (2022-06-01)

TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood
by: Roberta Amoriello, et al.
Published: (2021-06-01)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
by: Patrizia Natali, et al.
Published: (2022-05-01)

The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis
by: Raffaella Candeloro, et al.
Published: (2025-02-01)

Tetraspanins, GLAST and L1CAM Quantification in Single Extracellular Vesicles from Cerebrospinal Fluid and Serum of People with Multiple Sclerosis
by: Rocío Del Carmen Bravo-Miana, et al.
Published: (2024-10-01)